Lack of association between herpes simplex virus type 2 infection and cervical cancer-taq man realtime PCR assay findings

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 339-342

  Farivar, Taghi Naserpour ^a   Johari, Pouran ^a   Shafei, Shilan ^a   Najafipour, Reza ^a  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical cancer; Iranain women; Realtime PCR; RHSV 2

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENETICS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; AGED; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84864885256     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.339     Document Type: Article

References (26)

1. Anonymous (2006). Announcement the society of Gynecologic oncologists' statement on a cervix cancer vaccine. Gynecol Oncol, 10, 377.
2. Brady R, Bernstein D (2004). Treatment of herpes simplex infection. Antiviral Res, 61, 73-81.
3. Di Paolo J, Woodworth CD, Coutlee F, et al (1998). Relationship of stable integration of herpes simplex virus 2 Bgl II N sub-fragment Xho-2 to malignant transformation of human Papilloma virus-immortalized cervical kerationcytes. Int J Cancer, 76, 865-71.
4. Disease Control and Prevention, and National Cancer Institute; 2010. Available at: http://www.cdc.gov/uscs
5. Hoenil J, Weon K (2005). Implications of HPV infection in uterine cervical cancer. Cancer Therapy, 3, 419-34.
6. Jalouli J, Ibrahim SO, Mehrotra R, et al (2010). Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol, 130, 1306-11
7. Jones C,(1995)Cervical cancer: is herpes simplex virus type II a cofactor? Clin Microbiol Rev, 8, 549-56.
8. Kanerva A, Lavilla-Alonso S, Raki M (2008). Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses. PLoS, 3, e2917
9. Kjaer SK, Villiers E, Haugaard BJ, et al (2006) Human papillomavirus, herpes simplex virus & cervical cancer incidence in Greenland & Denmark. Int J Cancer, 41, 518-24.
10. Kwansniewska A, Korobowicz E, Zdunek M, et al (2009). Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples. Eur J Gynecol Oncol, 30, 65-70.
11. Linda W (2002). Herpes simplex virus-2 may increase risk of cervical cancer. J Natl Cancer Inst, 94, 1591.
12. Lulitanond V, Chantratita W, Thammaprasert K, et al (1994). Detection of herpes simplex virus type BglN fragment in paraffin-embedded cervical tissue section using nested polymerase chain reaction. Mol Cell Probes, 8, 441-7.
13. Menczer J (2003). The low incidence of cervical cancer in Jewish women: has the puzzle finally been solved?. Isr Med Assoc, 5, 120-3.
14. Moradi N, Salehi R, Tamizifar H, et al (2005). Evaluation of co infection with human papilloma virus (HPV) and Herpes simplex virus in patients with various grades of cervical. J Isfahan Med School, 22, 24-32.
15. Naserpour Farivar T, Johari P, Pahlavan AA, et al (2011). Agreement rate of rapid urease test, conventional PCR, and Scorpion real-time PCR in detecting Helicobacter pylori from tonsillar samples of patients with chronic tonsillitis. J Glob Infect Dis, 4, (in press).
16. Newcomb WW, Brown JC (2009). Time dependent transformation of the herpesvirus tegument. J Virol, 83, 8082-9.
17. Ohana B, Lipsen M,Vered S, et al (2000). Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies. Clin Diagn Lab Immunol, 27, 904-8.
18. Partridge JM, Koutsky LA (2006). Genital human papillomavirus infection in men. Lancet Infect Dis, 6, 21- 31.
19. Smith J, Herrero R, Bosetti C, et al (2002). Herpes simplex virus 2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst, 94, 1604- 13.
20. Sapountzi-Krepia D, Roupa Z, Binioris S, et al (2001). Cervical intraepithelial dysplasia (CIN 3) and history of herpes genitalis (HSV2) in women living in Attica, Greece. In Vivo, 15, 525-8.
21. Sawamura T, Kikuchi A, Wakayama Y, et al (2011). Evaluation and validation of a pretreatment method for automated genomic DNA and RNA extraction from clinical formalin-fixed paraffin-embedded samples using the MagNA Pure Compact System. Clin Lab, 57, 807-10.
22. Szostek S, Zawilinska B, Klimek M, et al (2009). Is the presence of herpes virus in cervical secretions prognostic factor for cervical pathology in HPV-Positive women?. Przel Epidemiol, 63, 97-101.
23. Szostek S, Zawilinska B, Kopec J, et al (2009). Herpesviruses as possible co factors in HPV-16-related oncogenesis. Acta Biochim Pol, 56, 337-42.
24. Yamakawa Y, Forslund O, Chva K, et al (1994). Detection of the BC24 transforming fragment of the herpes simplex virus type 2 (HSV-2) DNA in cervical carcinoma tissue by polymerase chain reaction. APMIS, 102, 401-6.
25. Uribe-Salas F, Conde-Glez CJ, Juárez-Figueroa L, et al (2003). Sociodemographic dynamics and sexually transmitted infections in female sex workers at the Mexican-Guatemalan border. Sex Transm Dis, 30, 266- 71.
26. Zereu M, Zettler C, Cambruzzi E, et al (2007). Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix. Gynecol Oncol, 105, 172-5